Impact of dose reductions of platinum compounds on survival in stage IIIB/IV non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Yumuk, P. F. [1 ]
Teomete, M. [1 ]
Dane, F. [1 ]
Cabuk, D. [1 ]
Basaran, G. [1 ]
Turhal, N. S. [1 ]
机构：
[1] Marmara Univ, Med Sch Hosp, Istanbul, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19055
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PLATINUM BASED CHEMOTHERAPY IN STAGE IIIB AND IV NON-SMALL CELL LUNG CANCER (NSCLC) - THE EFFECT ON SURVIVAL
    Mobarek, N. A.
    LUNG CANCER, 2009, 64 : S57 - S57
  • [2] Therapy for stage IIIB and stage IV non-small cell lung cancer
    Kim, TE
    Murren, JR
    CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 209 - +
  • [3] Vinorelbine (VNR) and carboplatinum (CAR) in patients with stage IIIB/IV non-small cell lung cancer (NSCLC).
    von Bültzingslöwen, F
    ANNALS OF ONCOLOGY, 2000, 11 : 119 - 119
  • [4] Clinicopathologic Characteristics And Predictors Of Survival In Stage Iv Non-Small Cell Lung Cancer (nsclc)
    Duma, N.
    Listo, M.
    Osorio, C.
    Zhang, S.
    Kang, M.
    Abu-Ihweij, K.
    Harper, H.
    Gutierrez, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [5] Impact of Metastatic Location on Survival in Stage-IV Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy
    Naqash, A. R.
    Jonnalagadda, S.
    Macherla, S.
    Polsani, S.
    Muzaffar, M.
    Cherry, C.
    Karim, N. Abdel
    Walker, P.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S464 - S464
  • [6] Survival Impact of Patient Enrollment in Antineoplastic Drug Trials for Stage IV Non-Small Cell Lung Cancer (NSCLC)
    Goulart, B.
    Silgard, E.
    Stricker, K.
    Eaton, K.
    Martins, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S995 - S995
  • [7] Survival Impact of Surgery in the Treatment of Stage IIIB-IVA Non-Small Cell Lung Cancer
    Park, J. Y.
    Jang, S. H.
    Kim, H. I.
    Kim, J.
    Park, S.
    Hwang, Y. I.
    Jung, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S898 - S898
  • [8] Definitive Dose Thoracic Radiotherapy In Oligometastatic Stage IV Non-small Cell Lung Cancer (NSCLC)
    Xanthopoulos, E.
    Fernandes, A. T.
    Apisarnthanarax, S.
    Christodouleas, J.
    Eaby-Sandy, B.
    Langer, C. J.
    Evans, T. L.
    Lin, L.
    Hahn, S. M.
    Rengan, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S620 - S620
  • [9] Survival impact of surgery in the treatment of stage IIIB-IVA non-small cell lung cancer
    Jang, Seung Hun
    Park, Sojung
    Lee, Chang Youl
    Park, Ji Young
    Kim, Joo-Hee
    Park, Sunghoon
    Hwang, Yong Il
    Jung, Ki-Suck
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [10] CHEMOTHERAPY IN STAGE IIIB AND IV NON-SMALL CELL LUNG CANCER: PROGNOSTIC FACTORS
    Racil, H.
    Rouhou, S. Cheikh
    Tlili, F.
    Zarrouk, M.
    Chaouch, N.
    Chabbou, A.
    LUNG CANCER, 2009, 64 : S58 - S58
12345